ID: ALA5193517
Chembl Id: CHEMBL5193517
PubChem CID: 168287024
Max Phase: Preclinical
Molecular Formula: C12H15FN4S
Molecular Weight: 266.35
Associated Items:
Canonical SMILES: CN/C(=N\C#N)NCCSCc1ccc(F)cc1
Standard InChI: InChI=1S/C12H15FN4S/c1-15-12(17-9-14)16-6-7-18-8-10-2-4-11(13)5-3-10/h2-5H,6-8H2,1H3,(H2,15,16,17)
Standard InChI Key: DGZPXSYLNKZHSO-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 266.35 | Molecular Weight (Monoisotopic): 266.1001 | AlogP: 1.70 | #Rotatable Bonds: 5 |
| Polar Surface Area: 60.21 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
| #RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 2.08 | CX LogD: 2.08 |
| Aromatic Rings: 1 | Heavy Atoms: 18 | QED Weighted: 0.37 | Np Likeness Score: -1.85 |
| 1. Shinya S, Kawai K, Kobayashi N, Karuo Y, Tarui A, Sato K, Otsuka M, Omote M.. (2022) Fluorophenylalkyl-substituted cyanoguanidine derivatives as bacteria-selective MATE transporter inhibitors for the treatment of antibiotic-resistant infections., 74 [PMID:36215813] [10.1016/j.bmc.2022.117042] |
Source(1):
